Hot flushes during ADT for prostate cancer - a clinical rationale for a neurokinin 3 receptor antagonist
Nat Rev Urol
.
2026 Apr 28.
doi: 10.1038/s41585-026-01147-6.
Online ahead of print.
Authors
Martino Pedrani
1
,
Bertrand Tombal
2
,
Pierre Blanchard
3
,
Silke Gillessen
4
5
Affiliations
1
Istituto Oncologico della Svizzera Italiana, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. martino.pedrani@eoc.ch.
2
Institut de Recherche Clinique, Cliniques Universitaires Saint Luc, Brussels, Belgium.
3
Department of Radiation Oncology, Université Paris-Saclay, Gustave-Roussy, Oncostat U1018 Inserm, Villejuif, France.
4
Istituto Oncologico della Svizzera Italiana, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
5
Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland.
PMID:
42050224
DOI:
10.1038/s41585-026-01147-6
No abstract available